Seth P Epstein

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. pmc HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease
    Seth P Epstein
    Department of Ophthalmology, Mount Sinai Medical Center, New York, NY, USA
    Exp Eye Res 111:95-104. 2013
  2. pmc Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model
    Seth P Epstein
    Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York, USA
    BMC Ophthalmol 6:22. 2006
  3. pmc Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells
    Seth P Epstein
    Department of Ophthalmology, Mount Sinai Medical Center, New York, NY 10029 6574, USA
    J Ocul Pharmacol Ther 25:113-9. 2009
  4. pmc Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells
    Seth P Epstein
    Department of Ophthalmology, Mount Sinai Medical Center, New York, New York, NY 10029 6574, USA
    J Ocul Pharmacol Ther 25:415-24. 2009
  5. pmc sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model
    Yi Wei
    Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York 10029, USA
    Invest Ophthalmol Vis Sci 52:4780-8. 2011
  6. doi request reprint Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells
    Alejandro Babayán Sosa
    Department of Ophthalmology, Mount Sinai Medical Center, New York, NY 10029 6574, USA
    Cornea 27:930-4. 2008
  7. pmc P63 expression levels in side population and low light scattering ocular surface epithelial cells
    Seth P Epstein
    Department of Ophthalmology and Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York, USA
    Trans Am Ophthalmol Soc 103:187-99; discussion 199. 2005

Detail Information

Publications7

  1. pmc HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease
    Seth P Epstein
    Department of Ophthalmology, Mount Sinai Medical Center, New York, NY, USA
    Exp Eye Res 111:95-104. 2013
    ....
  2. pmc Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture model and against adenovirus keratoconjunctivitis in a rabbit model
    Seth P Epstein
    Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York, USA
    BMC Ophthalmol 6:22. 2006
    ..A leading CTC compound (CTC-96), a Co(III) chelate, was found to have potent in vitro and in vivo antiviral efficacy against herpes viruses. In this study CTC-96 is being tested for possible anti-Adenovirus activity...
  3. pmc Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells
    Seth P Epstein
    Department of Ophthalmology, Mount Sinai Medical Center, New York, NY 10029 6574, USA
    J Ocul Pharmacol Ther 25:113-9. 2009
    ..To evaluate the potential toxicity of these common components and their comparative effects on the ocular surface, a tissue culture model utilizing immortalized corneal and conjunctival epithelial cells was utilized...
  4. pmc Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells
    Seth P Epstein
    Department of Ophthalmology, Mount Sinai Medical Center, New York, New York, NY 10029 6574, USA
    J Ocul Pharmacol Ther 25:415-24. 2009
    ..To evaluate the inflammation BAK causes to the ocular surface, enzyme linked immunosorbant assays (ELISAs) were utilized to quantify the levels of inflammatory biomarkers in response to BAK and/or H(2)O(2)...
  5. pmc sPLA2-IIa amplifies ocular surface inflammation in the experimental dry eye (DE) BALB/c mouse model
    Yi Wei
    Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York 10029, USA
    Invest Ophthalmol Vis Sci 52:4780-8. 2011
    ..However, its role in ocular surface inflammation remains unclear. An experimentally induced BALB/c mouse dry eye (DE) model was used to elucidate the role of sPLA2-IIa in ocular surface inflammation...
  6. doi request reprint Evaluation of toxicity of commercial ophthalmic fluoroquinolone antibiotics as assessed on immortalized corneal and conjunctival epithelial cells
    Alejandro Babayán Sosa
    Department of Ophthalmology, Mount Sinai Medical Center, New York, NY 10029 6574, USA
    Cornea 27:930-4. 2008
    ..To evaluate the toxicity of a variety of the fluoroquinolone antibiotics on the ocular surface by using tissue culture models of corneal epithelial cells and conjunctival epithelial cells...
  7. pmc P63 expression levels in side population and low light scattering ocular surface epithelial cells
    Seth P Epstein
    Department of Ophthalmology and Black Family Stem Cell Institute, Mount Sinai School of Medicine, New York, New York, USA
    Trans Am Ophthalmol Soc 103:187-99; discussion 199. 2005
    ....